期刊
JOURNAL OF KOREAN MEDICAL SCIENCE
卷 36, 期 45, 页码 -出版社
KOREAN ACAD MEDICAL SCIENCES
DOI: 10.3346/jkms.2021.36.e312
关键词
Coronavirus Disease 2019 (COVID-19); COVID-19 Vaccination; Multisystem Inflammatory Syndrome; Methylprednisolone
资金
- Soonchunhyang University Research Fund [10210052]
Increasing number of people vaccinated are experiencing adverse reactions, including a case of multisystem inflammatory syndrome (MIS) after ChAdOx1 COVID-19 vaccination, characterized by low blood pressure, fever, edema, and systemic inflammation. Prompt diagnosis and treatment are crucial in managing MIS post COVID-19 vaccination.
As the number of people vaccinated increases, people who complain of adverse reactions continue to occur. We experienced a case characterized by low blood pressure, persistent fever, edema due to increased systemic vascular permeability, and systemic inflammation confirmed by image and laboratory examinations after ChAdOx1 coronavirus disease 2019 (COVID-19) vaccination. The diagnostic criteria for multisystem inflammatory syndrome (MIS) in adults are known as fever of 3 days or more in adults, 2 or more mucocutaneous/gastrointestinal/neurologic symptoms, elevation of inflammatory markers, and clinical/ imaging diagnosis of heart failure. A 67-year-old man who was medicated for hypertension and diabetes was admitted complaining of fever, maculopapular rash, diarrhea, headache, chills, and dizziness 6 days after the first vaccination of ChAdOx1 nCoV-19 in Korea. The COVID-19 test was negative but with low blood pressure, leukocytosis, skin rash, pulmonary edema, and increased inflammation markers. His lab findings and clinical course were consistent with those of MIS after COVID-19 vaccination. He was medicated with methylprednisolone 1 mg/kg and diuretics and recovered rapidly. He was discharged after 2 weeks and confirmed cure at outpatient clinic. We report an MIS case after COVID-19 vaccination in Korea.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据